Monitoring and Feedback in Substance Abuse Treatment
2 other identifiers
interventional
327
1 country
4
Brief Summary
This is a three-staged study to develop and evaluate a monitoring instrument and associated intervention, as follows: Stage 1 - Develop and determine the reliability, validity, and sensitivity to change of a brief Multidimensional Monitoring Instrument (MMI) for clients in outpatient substance abuse treatment (SAT). Stage 2 - Develop a Monitoring and Feedback Intervention (MFI) that uses the MMI. As part of this process, create a manual, training materials, and competence and adherence measures, and conduct a feasibility study within an outpatient SAT unit to refine the intervention and associated materials and measures. Stage 3 - Conduct a randomized clinical trial (RCT) to determine the preliminary efficacy of the MFI compared to treatment as usual (TAU) for clients in outpatient SAT. In this pilot study, it is hypothesized that the MFI will positively impact the treatment process, and short-term, during treatment, outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Sep 2007
Longer than P75 for phase_1
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 1, 2011
CompletedFirst Posted
Study publicly available on registry
November 4, 2011
CompletedNovember 18, 2023
November 1, 2023
3.9 years
November 1, 2011
November 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Treatment attendance
Client participant's treatment attendance is obtained from treatment program clinical record.
3 months after consent
Secondary Outcomes (3)
Urine screen results
3 months after consent
Discharge status
3 months after consent
Discharge date
3 months after consent
Study Arms (2)
Monitoring and Feedback Intervention
EXPERIMENTALTreatment as usual
NO INTERVENTIONInterventions
Clients participate in standard treatment and complete the MMI weekly with their counselors at the beginning of each individual counseling session. Counselors have been trained to administer the MMI and will have access to the data to use during sessions.
Eligibility Criteria
You may qualify if:
- Client receiving intensive outpatient treatment at participating program
- Counselor employed by participating program
You may not qualify if:
- Client unable to speak English
- Client too cognitively impaired to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Rehab After Work
Philadelphia, Pennsylvania, 19102, United States
Presbyterian Medical Center
Philadelphia, Pennsylvania, 19104, United States
Sobriety Through Outpatient
Philadelphia, Pennsylvania, 19132, United States
Jefferson Intensive Outpatient
Philadelphia, Pennsylvania, 19146, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John S Cacciola, Ph.D.
Treatment Research Institute
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 2011
First Posted
November 4, 2011
Study Start
September 1, 2007
Primary Completion
August 1, 2011
Study Completion
August 1, 2011
Last Updated
November 18, 2023
Record last verified: 2023-11